Healome Therapeutics

Healome Therapeutics is a biotech company in Birmingham, United Kingdom, founded in 2021. It has raised $2.5M across 1 round, most recently a $2.5M Seed in July 2026.

Developing Solutions for Ocular Surface Diseases

Headquarters
Birmingham
Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$2.5M
Last Round
$2.5M SeedJul 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Healome Therapeutics is an ophthalmology and ocular drug delivery company aiming to improve the safety, effectiveness, and usability of ocular drugs and treatment of ocular surface conditions. Healome has developed an eye drop matrix technology that behaves like a liquid when dropped on the eye, then restructures into a clear, lubricating, protective matrix able to deliver a broad range of drugs, from small molecules to complex biologics. The company aims to enhance the therapeutic value of existing ocular medicines through reformulation and to develop novel therapeutics that could transform the management of ocular surface health.

Summary

It lists 1–10 employees. It has raised $2.5M in total across 1 round, most recently a $2.5M Seed round in Jul 2026.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundJul 2026
$2.5M

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Healome Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/healome-therapeutics"><img src="https://indexed.vc/api/badge/company/healome-therapeutics" alt="Healome Therapeutics on Indexed.vc" width="260" height="76" /></a>